GS-5745 for CF Lung Inflammation in Cystic Fibrosis

GS-5745 is a monoclonal antibody that may help reduce inflammation in the lungs, leading to improved lung function in people with cystic fibrosis (CF).1

How GS-5745 works

GS-5745 inhibits matrix metalloproteinase 9 (MMP-9) — an extracellular enzyme involved in matrix remodeling, tumor growth, and metastasis — and has antineoplastic potential. Once administered, GS-5745 binds to MMP-9 and inhibits its enzymatic activity. This prevents extracellular matrix protein degradation and, potentially, blocks tumor growth, invasion, and metastasis. MMP-9 plays an important role in the degradation of collagens and proteoglycans, and increased MMP-9 activity has been linked to increased invasion and cancer metastasis.2

GS-5745 studies

Preclinical studies showed that blocking MMP-9 alters the tumor microenvironment, and it is associated with greater chemotherapy penetration and improved anti-tumor immunity.3

A Phase 2 study to evaluate the effect of GS-5745 on FEV1 (forced expiration in one second, a measure of lung health) in adults with cystic fibrosis (NCT02759562) is recruiting participants. The study will evaluate GS-5745’s effect on pre-bronchodilator FEV1 in adults with CF after eight weeks of treatment. There will be two parts to the study: In the first, GS-5745 at 600 mg or placebo will be administered for eight weeks. In the second, GS-5745 at 300 mg, 150 mg, or placebo will be administered for eight weeks. Part 2 will be initiated once Part 1 is completed.

Its primary goal is absolute change in pre-bronchodilator FEV1 percent predicted, as measured from baseline to week eight.

The study is expected to be completed in March 2019.

Cystic Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



Featured Column

Don’t Overlook Emotional Wellness When Dealing With Chronic Illness

A banner for Lara's column, depicting a car on a road trip winding through a forest.
Living with a chronic illness can affect emotional wellness, writes columnist Lara Govendo, who offers up some ideas for managing both.

Read the Column

Your CF Community

Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.